Latest news with #Hers
Yahoo
a day ago
- Business
- Yahoo
Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock?
Hims & Hers stock is on the upswing after the company secured a weight-loss drug partnership. Hims & Hers is acquiring its way into Europe and wants to build more personalized drugs for its telehealth customers. Shares have soared, but still have a ton of potential for patient long-term shareholders. 10 stocks we like better than Hims & Hers Health › Many companies have failed to disrupt the complicated U.S. healthcare market. Hims & Hers (NYSE: HIMS) may finally be succeeding in cracking the code. The online telehealth platform focuses on circumventing the insurance market; its business of selling affordable medications directly to individuals is growing like a weed, and expects to generate $6.5 billion in revenue by 2030. It has had a tumultuous start to 2025, as Hims & Hers waged a battle to sell new weight loss medications on its online marketplace. Now, with momentum back on its side, the stock is up 118% year to date and 446% in the last five years. Let's take a deeper look at this company, and see whether you might want to buy Hims & Hers stock for your portfolio now. Hims & Hers' model is simple. It has two separate web platforms -- Hims for men and Hers for women -- that sell medications and deliver to customers' front doors. It began with sexual health, but has moved into dermatology, hair loss, mental health, and now weight loss medications. A key to its success has been avoiding the insurance market with products that don't break the bank. Customers loathe dealing with health insurers in the United States, and sometimes would rather not use insurance at all. Plus, some of these products aren't covered by insurance. This strategy has helped the company close in on over $2 billion in projected revenue in 2025. To keep up this impressive growth, Hims & Hers wants to offer weight loss medications, which have been a blockbuster set of drugs for the pharmaceutical market. For a while the popularity of these drugs, such as Novo Nordisk's Wegovy, left them in short supply; that allowed third parties such as Hims & Hers to produce them as a compounding pharmacy and sell them at much cheaper prices. This ended up generating $200 million of Hims & Hers' $1.4 billion in 2024 revenue. But with the shortage of Wegovy over and the compounding pharmacy exception ended, the company's weight-loss business was at a major turning point. Luckily, at the end of April Hims & Hers announced a partnership with Novo Nordisk that seems to resolve this issue: It gives Hims & Hers the ability to sell Wegovy directly on its platform. Hims & Hers is not an exclusive supplier of the drug -- or any drugs on its marketplaces, to be fair -- but it hopes to use its subscription business model, marketing expertise, and simplified user proposition to drive sales for Novo Nordisk in the huge obesity-care market. Besides weight loss drugs, Hims & Hers has more ambitions to reach its goal of $6.5 billion in revenue by 2030. Just recently, the company announced its intent to acquire European competitor Zava so it could expand its telehealth service to Europe. The acquisition will add a platform with 1.3 million active customers in the U.K., Germany, France, and Ireland. It makes sense that Hims & Hers can supercharge growth for the platform with its plethora of medications offered to customers, keen marketing skills, and subscription-based selling model. Over the long run, Hims & Hers aims to make healthcare for its customers more personalized. This includes unique drug combinations, its own outsourcing facility, and at-home testing capabilities. Details remain sparse, but the vision is clear: disrupting more and more of the trillions of dollars spent on healthcare by building a business that people actually enjoy interacting with. This is why 2.4 million active customers use Hims & Hers today. A revenue goal of $6.5 billion seems well within reach by 2030. Hims & Hers is only at 2.4 million active customers, and there are tens of millions of people in the United States alone who could start using or switch to one of its telehealth platforms. Add on the Zava acquisition in Europe, and the runway for growth gets even larger. The company has an impressive gross profit margin of 77%, which should lead to high levels of profitability at scale. On $6.5 billion in future revenue, it could very well post a net profit margin of over 20%, and achieve $1.5 billion in bottom-line profits and free cash flow. A 20% profit margin is easily achievable because of its high gross margins and the fact it currently spends 40% of revenue on marketing today, a figure that has come down over time and should come down even more as Hims & Hers keeps scaling. However, Hims & Hers has played fast and loose with laws and regulations in the past. It sold weight loss drugs when the legality of doing so was unclear, and although that dispute seems to have been resolved, management could easily start playing with fire again and burn its reputation as a trusted provider of medications. Otherwise, this looks like a fantastic growth stock that just doubled its addressable market with the Zava acquisition. Today, Hims & Hers has a market cap of $12.3 billion. You might think it's overvalued because of the stock's recent run-up in price, but the numbers show that patient investors could be rewarded by holding for the long term. A $12.3 billion market cap is only around 8 times my 2030 earnings estimate of $1.5 billion, which would be a dirt cheap price-to-earnings (P/E) ratio for a fast-growing company compared to the current market cap. Most likely, the stock will be valued at a higher multiple than 8, meaning that the stock will be higher in five years. It doesn't come without risks, but if you're a growth investor, you might love Hims & Hers stock for its long-term potential. Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Hims & Hers Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 173% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Brett Schafer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
01-06-2025
- Health
CDC adjusts guidance on COVID vaccines
Dr. Jessica Shepherd, a women's health expert and chief medical officer of "Hers," discusses the recent conflicting information on the COVID vaccine for children and pregnant women. June 1, 2025
Miami Herald
22-05-2025
- Entertainment
- Miami Herald
What your streaming vs. scrolling habits reveal about your mental health
We all know that spending too much time on screens is unhealthy, but do different screens have different impacts on our mental health? The answer, according to a 2025 Hers study, is yes. In fact, one simple question, "Do you prefer streaming TV or scrolling social media?" reveals key differences in our self-perceptions, emotional stability, mental wellness, and more. So which one is better? Well, it's complicated. When it comes to screen time, binge watching Netflix and scrolling TikTok are not apples-to-apples, so it makes sense that their impact on our mental health isn't either. Here's a look at three key differences in streamers' vs. scrollers' mental health profiles. Scrollers Have a Higher Self-Image Overall When it comes to how people perceive themselves, those who prefer scrolling social media to streaming TV were notably more upbeat on several criteria. They feel more attractive (63% of scrollers rate themselves as a 4 or 5 on attractiveness on a 5-point scale vs. 57% of streamers), healthy (62% vs. 57%), and sexual (54% vs. 49%). Scrollers were also more likely than streamers to agree with the statement, "I love the way I look right now" (41% vs. 37%). However, this higher self-perception isn't necessarily translated to feeling more secure. Scrollers actually report feeling slightly more insecure than streamers (25% vs. 22%, respectively), perhaps giving a nod to the negative impacts of comparison culture. Both streamers and scrollers reported feeling equally confident, with 65% of scrollers describing themselves as such (a 4 or 5 on a 5-point scale) vs. 64% of streamers. That said, the areas where each group felt more confident differed. For example, scrollers have more physical confidence. They reported feeling more confident socially (24% vs. 22%), physically (21% vs. 19%), and sexually (17% vs. 15%). Streamers, on the other hand, ranked themselves as more confident in their caregiving (24% vs. 20%), overall mental wellness (20% vs. 17%), and philosophical sense of self (16% vs. 14%). They were also more likely than scrollers to name "emotionally stable" as a top personality trait (13% vs. 10.5%) While the differences in these percentages aren't necessarily statistically significant alone, taken together they paint a picture of two different types of self-confidence-one more physical and social and the other more emotional and philosophical. Streamers Are More Proactive About Their Mental Health Mental health is more top-of-mind among those who prefer streaming TV vs. those who prefer scrolling social media. 25.5% of streamers say they have experienced more stress, anxiety, and burnout in the past five years vs. 21% of scrollers, and 26% of streamers say they've experienced a mental health condition in their life as compared to 23% of scrollers. Furthermore, streamers were 50% more likely than scrollers to say "stressed" is one of their top personality traits (15% vs. 10%) and, outside of money, "my mental health" is a bigger stressor for streamers (18%) vs. scrollers (14%). Streamers are also more likely to recognize the role their mental health has on their overall confidence: 18% say their mental health impacts their confidence (either for better or for worse) vs. 14% of people who prefer scrolling social media. Perhaps because mental health is top-of-mind among streamers, they also report being more proactive about it. 23% say that, in the past five years, they've been more proactive about their mental health as compared to 21% of scrollers. And 14% of streamers say they're "at my full potential" with regard to their mental health vs. 12% of scrollers. Whether you're more of a streamer or a scroller, there are things you can do to be more proactive about your own mental health, including limiting screen time to get outside, choosing streaming platforms that are better for your mental health, and only following accounts on social media that make you feel good. Scrollers Are Younger and More Diverse It's important to note that there are also demographic differences between scrollers and streamers that could account for some of the results in this study. Those who prefer scrolling to streaming are younger on average-36.5 years old vs. 40.7 years old-with a higher concentration of 18-24 year olds than those who prefer streaming (22% vs. 13%). Scrollers are also more diverse, with 47% being people of color vs. 40% of streamers. And despite their age difference, scrollers reported higher household income than streamers ($94,000 annually vs. $88,500). However, on almost every other marker, these two groups appear very similar, making their differing mental health markers arguably more psychographic than demographic. For example, there was no significant difference in where they lived, with equal representation among both groups across the country. They were equally likely to be politically aligned with the Democratic, Republican, or Independent parties. And there were as many parents and nonparents in both groups. Scrollers skewed slightly more female than streamers (53% vs. 51%), but not significantly. Data and Methodology This study is based on a 7,100-person online survey, which included (1) 5,000 18-to-65-year-old respondents in the top 50 metropolitan areas (100 respondents per city); (2) 5,000 18-65-year-old respondents in each of the 50 states (100 respondents per state); and (3) a nationally representative sample of 500 18-to-65-year-old respondents to contextualize results. These three categories are not mutually exclusive; some respondents fall within more than one category. The study was fielded in January 2025. Findings were analyzed by 190 demographic and psychographic cuts, including city, region, gender (when Hers refers to "women" and "men," we include all people who self-identify as such), age, race and ethnicity, relationship status, parenting status, sexual orientation (heterosexual, bisexual, gay, lesbian, pansexual, asexual, queer, etc.), fandoms (music, sports, etc.), and fitness and diet preferences, among other areas of interest. All data in this study are from this source, unless otherwise noted. Independent research firm, Culture Co-op, conducted and analyzed research and findings. This story was produced by Hers and reviewed and distributed by Stacker. © Stacker Media, LLC.
Yahoo
20-05-2025
- Health
- Yahoo
How to get weight loss drugs without insurance
(NewsNation) — While weight loss medications are usually not covered by insurance, there are other ways to secure a medication without a provider. There are 13 states whose Medicaid programs allow for GLP-1 drugs to be used for the treatment of obesity. Some GLP-1 drugs are only covered by insurance when prescribed for diabetes. Here are your options for getting medication without insurance. If you are looking to get a weight loss drug but lack insurance coverage, telehealth websites such as Ro, Hers and Mochi Health sell GLP-1 drugs for lower prices than what you'd pay at a pharmacy, with plans for certain medications starting at $69 per month. GoodRx also offers coupons that lower the price of some weight loss medications if purchased at a pharmacy. Dental expenses you can pay for using an HSA In April, drugmaker Novo Nordisk announced it would be collaborating with telehealth services such as Hims and LifeMD to start home shipments of its medication Wegovy for self-paying customers at a cost of $499 per month. Eli Lilly sells its weight loss medication Zepbound directly from its pharmacy, LillyDirect, between $349 to $499 per month depending on the dosage. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
18-05-2025
- Health
Doctors saved baby's life with gene fix for deadly rare disease
Dr. Jessica Shepherd, chief medical officer for Hers, joins ABC News Live to discuss the first-of-its-kind approach to gene-editing.
